Stock & Company Details
Conduit Pharmaceuticals Inc $CDT
Price:
N/A
N/A
N/A
$617K
52 Week High:
N/A
10 Day Average Volume:
N/A
0.00
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CDT technical indicators
Latest Conduit Pharmaceuticals Inc (CDT) indicator readings as of 2026-10-09.
CDT's 14-day RSI is 45.4, in neutral territory. At $0.72 it is trading 55.8% below its 200-day moving average of $1.63, and below its 50-day average of $1.54. Price sits in the middle of its Bollinger Bands ($-0.39 to $1.48). ADX reads 32.8, indicating a trending market.
Overview
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
Finance Bot
Ask your questions
Start by typing a question below.
